Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease

References

• Wehkamp J, Gotz M, Herrlinger K, et al. Inflammatory bowel disease. Dtsch Arztebl Int. 2016;113(5):72–82.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107(1):3–11.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31(3):260–266.
   PubMed Web of Science ®Google Scholar
• Lamb CA, Kennedy NA, Raine T, IBD guidelines eDelphi consensus group, et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106.
   PubMed Web of Science ®Google Scholar
• Burri E, Beglinger C. Faecal calprotectin - a useful tool in the management of inflammatory bowel disease. Swiss Med Wkly. 2012;142:w13557
   PubMed Web of Science ®Google Scholar
• Ikhtaire S, Shajib MS, Reinisch W, et al. Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease. J Gastroenterol. 2016;51(5):434–446.
   PubMed Web of Science ®Google Scholar
• Ayling RM, Kok K. Fecal calprotectin. Adv Clin Chem. 2018;87:161–190.
   PubMed Web of Science ®Google Scholar
• Burisch J, Jess T, Martinato M, ECCO -EpiCom, et al. The burden of inflammatory bowel disease in europe. J Crohns Colitis. 2013;7(4):322–337.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol. 2013;29(4):357–362.
   PubMed Web of Science ®Google Scholar
• Rocchi A, Benchimol EI, Bernstein CN, et al. Inflammatory bowel disease: a canadian burden of illness review. Can J Gastroenterol. 2012;26(11):811–817.
   PubMed Web of Science ®Google Scholar
• Vadstrup K, Alulis S, Borsi A, et al. Cost burden of Crohn's disease and ulcerative colitis in the 10-year period before diagnosis-a danish register-based study from 2003-2015. Inflamm Bowel Dis. 2019;26:1377–1382.
   Web of Science ®Google Scholar
• Vadstrup K, Alulis S, Borsi A, et al. Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016. Scand J Gastroenterol. 2020;55:41–46.
   PubMed Web of Science ®Google Scholar
• Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol. 2015;50(8):942–951.
   PubMed Web of Science ®Google Scholar
• Riaz MS, Atreja A. Personalized technologies in chronic gastrointestinal disorders: self-monitoring and remote sensor technologies. Clin Gastroenterol Hepatol. 2016;14(12):1697–1705.
   PubMed Web of Science ®Google Scholar
• Aguas M, Del Hoyo J, Faubel R, et al. Telemedicine in the treatment of patients with inflammatory bowel disease. Gastroenterol Hepatol. 2017;40(9):641–647.
   PubMed Web of Science ®Google Scholar
• Heida A, Dijkstra A, Muller Kobold A, et al. Efficacy of home telemonitoring versus conventional follow-up: a randomized controlled trial among teenagers with inflammatory bowel disease. J Crohns Colitis. 2018;12(4):432–441.
   PubMed Web of Science ®Google Scholar
• Cross RK, Cheevers N, Rustgi A, et al. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (uc HAT). Inflamm Bowel Dis. 2012;18(6):1018–1025.
   PubMed Web of Science ®Google Scholar
• Carlsen K, Jakobsen C, Houen G, et al. Self-managed ehealth disease monitoring in children and adolescents with inflammatory bowel disease: a randomized controlled trial. Inflamm Bowel Dis. 2017;23:357–365.
   PubMed Web of Science ®Google Scholar
• Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'constant-care' approach. Gut. 2010;59(12):1652–1661.
   PubMed Web of Science ®Google Scholar
• Li SX, Thompson KD, Peterson T, et al. Delivering high value inflammatory bowel disease care through telemedicine visits. Inflamm Bowel Dis. 2017;23(10):1678–1681.
   PubMed Web of Science ®Google Scholar
• Jackson BD, Gray K, Knowles SR, et al. Ehealth technologies in inflammatory bowel disease: a systematic review. ECCOJC. 2016;10(9):1103–1121.
   Web of Science ®Google Scholar
• Del Hoyo J, Nos P, Bastida G, et al. Telemonitoring of crohn's disease and ulcerative colitis (teccu): cost-effectiveness analysis. J Med Internet Res. 2019;21(9):e15505
   PubMed Web of Science ®Google Scholar
• de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myibdcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017;390(10098):959–968.
   PubMed Web of Science ®Google Scholar
• Cross RK, Langenberg P, Regueiro M, et al. A randomized controlled trial of telemedicine for patients with inflammatory bowel disease (tele-ibd). Am J Gastroenterol. 2019;114:472–482.
   PubMed Web of Science ®Google Scholar
• Aguas Peris M, Del Hoyo J, Bebia P, et al. Telemedicine in inflammatory bowel disease: opportunities and approaches. Inflamm Bowel Dis. 2015;21(2):392–399.
   PubMed Web of Science ®Google Scholar
• Robinson A, Thompson DG, Wilkin D, et al. Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial. Lancet. 2001;358(9286):976–981.
   PubMed Web of Science ®Google Scholar
• Tu W, Xu G, Du S. Structure and content components of self-management interventions that improve health-related quality of life in people with inflammatory bowel disease: a systematic review, meta-analysis and meta-regression. J Clin Nurs. 2015;24(19-20):2695–2709.
   PubMed Web of Science ®Google Scholar
• Vinding KK, Elsberg H, Thorkilgaard T, et al. Fecal calprotectin measured by patients at home using smartphones - a new clinical tool in monitoring patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(2):336–344.
   PubMed Web of Science ®Google Scholar
• Elkjaer M, Burisch J, Voxen Hansen V, et al. A new rapid home test for faecal calprotectin in ulcerative colitis. Aliment Pharmacol Ther. 2010;31:323–330.
   PubMed Web of Science ®Google Scholar
• Heida A, Knol M, Kobold AM, et al. Agreement between home-based measurement of stool calprotectin and ELISA results for monitoring inflammatory bowel disease activity. Clin Gastroenterol Hepatol. 2017;15(11):1742–1749.e2.
   PubMed Web of Science ®Google Scholar
• Wei SC, Tung CC, Weng MT, et al. Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring. Intest Res. 2018;16(4):546–553.
   PubMed Web of Science ®Google Scholar
• Puolanne AM, Kolho KL, Alfthan H, et al. Is home monitoring of inflammatory bowel disease feasible? A randomized controlled study. Scand J Gastroenterol. 2019;54(7):849–854.
   PubMed Web of Science ®Google Scholar
• Ankersen DV, Weimers P, Marker D, et al. Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: a randomized-clinical trial. World J Gastroenterol. 2019;25(40):6158–6171.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson M, Bengtsson J, et al. Swedish inflammatory bowel disease register (swibreg) - a nationwide quality register. Scand J Gastroenterol. 2019;54(9):1089–1101.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, et al. The montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–753.
   PubMed Web of Science ®Google Scholar
• Baumann E, Czerwinski F, Reifegerste D. Gender-specific determinants and patterns of online health information seeking: results from a representative German Health Survey. J Med Internet Res. 2017;19(4):e92
   PubMed Web of Science ®Google Scholar
• Escoffery C. Gender similarities and differences for e-health behaviors among U.S. Adults. Telemed J E Health. 2018;24(5):335–343.
   PubMed Web of Science ®Google Scholar
• Celler B, Argha A, Varnfield M, et al. Patient adherence to scheduled vital sign measurements during home telemonitoring: Analysis of the intervention arm in a before and after trial. JMIR Med Inform. 2018;6(2):e15.
   PubMed Web of Science ®Google Scholar
• Kerby TJ, Asche SE, Maciosek MV, et al. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens (Greenwich)). 2012;14(10):668–674.
   PubMed Web of Science ®Google Scholar
• Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol. 2006;40(3):200–208.
   PubMed Web of Science ®Google Scholar
• Cross RK, Finkelstein J. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci. 2007;52(2):357–364.
   PubMed Web of Science ®Google Scholar